While melanotan I has been approved in Australia for highly specialised use, melanotan II has never been assessed by the TGA and its development as a potential medicine was stopped years ago due to safety reasons
Baan R, Grosse Y, Lauby-Secretan B, et al
Infections such as meningitis can cause severe pain at the base of the skull, often accompanied by other systemic symptoms
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
A significant portion of patients achieve their target weight within six months, though individual timelines vary based on starting weight, diet adherence, and activity level